(-)-epigallocatechin 3-gallate multiple interactions EXP 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of GLRX2 mRNA CTD PMID:22079256 1,2-dichloroethane increases expression ISO RGD:1317444 6480464 ethylene dichloride results in increased expression of GLRX2 mRNA CTD PMID:28960355 17beta-hydroxy-5alpha-androstan-3-one increases expression EXP 6480464 Dihydrotestosterone results in increased expression of GLRX2 mRNA CTD PMID:29581250 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1317444 6480464 Tetrachlorodibenzodioxin affects the expression of GLRX2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GLRX2 mRNA CTD PMID:23152189 2,6-dinitrotoluene affects expression ISO RGD:1307950 6480464 2, 6-dinitrotoluene affects the expression of GLRX2 mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of GLRX2 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl multiple interactions ISO RGD:1317444 6480464 [3 more ... CTD PMID:24378064 3,4-methylenedioxymethamphetamine increases expression ISO RGD:1317444 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in increased expression of GLRX2 mRNA CTD PMID:20188158 acetamide decreases expression ISO RGD:1307950 6480464 acetamide results in decreased expression of GLRX2 mRNA CTD PMID:31881176 benzo[a]pyrene increases expression ISO RGD:1317444 6480464 Benzoapyrene results in increased expression of GLRX2 mRNA CTD PMID:22228805 benzo[a]pyrene increases methylation EXP 6480464 Benzoapyrene results in increased methylation of GLRX2 exon, Benzoapyrene results in increased methylation of GLRX2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression EXP 6480464 Benzoapyrene results in increased expression of GLRX2 mRNA CTD PMID:31255691 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GLRX2 mRNA CTD PMID:19371625 bisphenol A increases expression ISO RGD:1307950 6480464 bisphenol A results in increased expression of GLRX2 mRNA CTD PMID:25181051 carbamazepine affects expression EXP 6480464 Carbamazepine affects the expression of GLRX2 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1317444 6480464 Nanotubes more ... CTD PMID:25554681 chlordecone decreases expression ISO RGD:1317444 6480464 Chlordecone results in decreased expression of GLRX2 mRNA CTD PMID:29980752 cisplatin affects response to substance EXP 6480464 GLRX2 protein affects the susceptibility to Cisplatin CTD PMID:16217747 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of GLRX2 mRNA CTD PMID:27392435 copper atom multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in decreased expression of GLRX2 mRNA CTD PMID:24690739 copper(0) multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in decreased expression of GLRX2 mRNA CTD PMID:24690739 crocidolite asbestos decreases expression ISO RGD:1317444 6480464 Asbestos, Crocidolite results in decreased expression of GLRX2 mRNA CTD PMID:29279043 Diallyl sulfide increases expression ISO RGD:1307950 6480464 allyl sulfide results in increased expression of GLRX2 mRNA CTD PMID:19768707 dibenzo[a,l]pyrene decreases expression EXP 6480464 dibenzoa, lpyrene results in decreased expression of GLRX2 mRNA CTD PMID:31255691 disulfiram multiple interactions EXP 6480464 [Disulfiram binds to Copper] which results in decreased expression of GLRX2 mRNA CTD PMID:24690739 diuron increases expression ISO RGD:1307950 6480464 Diuron results in increased expression of GLRX2 mRNA CTD PMID:21551480 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 elemental selenium affects activity ISO RGD:1307950 6480464 Selenium affects the activity of GLRX2 protein CTD PMID:19351701 elemental selenium affects expression ISO RGD:1307950 6480464 Selenium affects the expression of GLRX2 protein CTD PMID:19351701 finasteride increases expression ISO RGD:1307950 6480464 Finasteride results in increased expression of GLRX2 mRNA CTD PMID:24136188 flutamide increases expression ISO RGD:1307950 6480464 Flutamide results in increased expression of GLRX2 mRNA CTD PMID:24136188 genistein increases expression EXP 6480464 Genistein results in increased expression of GLRX2 mRNA CTD PMID:19371625 hexane decreases methylation ISO RGD:1307950 6480464 n-hexane results in decreased methylation of GLRX2 promoter CTD PMID:23740543 isotretinoin decreases expression EXP 6480464 Isotretinoin results in decreased expression of GLRX2 mRNA CTD PMID:20436886 mercury dibromide increases expression EXP 6480464 mercuric bromide results in increased expression of GLRX2 mRNA CTD PMID:26272509 mercury dibromide multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of GLRX2 mRNA CTD PMID:27188386 methyl methanesulfonate increases expression EXP 6480464 Methyl Methanesulfonate results in increased expression of GLRX2 mRNA CTD PMID:23649840 methylene blue multiple interactions ISO RGD:1317444 6480464 [Methylene Blue co-treated with MAPT protein mutant form] results in increased expression of GLRX2 mRNA CTD PMID:24556215 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of GLRX2 mRNA CTD PMID:28001369 , PMID:29581082 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-2-ethylhexylphthalate results in increased expression of GLRX2 mRNA CTD PMID:23360888 nefazodone increases expression ISO RGD:1307950 6480464 nefazodone results in increased expression of GLRX2 mRNA CTD PMID:24136188 nimesulide increases expression ISO RGD:1307950 6480464 nimesulide results in increased expression of GLRX2 mRNA CTD PMID:24136188 panobinostat multiple interactions EXP 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of GLRX2 mRNA CTD PMID:27188386 panobinostat increases expression EXP 6480464 panobinostat results in increased expression of GLRX2 mRNA CTD PMID:26272509 paraquat decreases expression ISO RGD:1317444 6480464 Paraquat results in decreased expression of GLRX2 mRNA CTD PMID:12732627 paraquat increases expression ISO RGD:1317444 6480464 Paraquat results in increased expression of GLRX2 mRNA CTD PMID:21371552 phenobarbital decreases expression ISO RGD:1307950 6480464 Phenobarbital results in decreased expression of GLRX2 mRNA CTD PMID:19768707 phenylmercury acetate increases expression EXP 6480464 Phenylmercuric Acetate results in increased expression of GLRX2 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of GLRX2 mRNA CTD PMID:27188386 phlorizin decreases expression ISO RGD:1317444 6480464 Phlorhizin results in decreased expression of GLRX2 mRNA CTD PMID:22538082 pirinixic acid multiple interactions ISO RGD:1317444 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of GLRX2 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:1317444 6480464 pirinixic acid results in decreased expression of GLRX2 mRNA CTD PMID:20813756 potassium chromate multiple interactions EXP 6480464 [potassium chromateVI co-treated with epigallocatechin gallate] results in decreased expression of GLRX2 mRNA CTD PMID:22079256 potassium chromate decreases expression EXP 6480464 potassium chromateVI results in decreased expression of GLRX2 mRNA CTD PMID:22079256 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of GLRX2 mRNA CTD PMID:21632981 rac-lactic acid decreases expression EXP 6480464 Lactic Acid results in decreased expression of GLRX2 mRNA CTD PMID:30851411 resveratrol increases expression EXP 6480464 resveratrol results in increased expression of GLRX2 mRNA CTD PMID:19371625 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-5-benzo1 more ... CTD PMID:27188386 selenium atom affects activity ISO RGD:1307950 6480464 Selenium affects the activity of GLRX2 protein CTD PMID:19351701 selenium atom affects expression ISO RGD:1307950 6480464 Selenium affects the expression of GLRX2 protein CTD PMID:19351701 sunitinib decreases expression EXP 6480464 Sunitinib results in decreased expression of GLRX2 mRNA CTD PMID:31533062 toluene affects expression ISO RGD:1307950 6480464 Toluene affects the expression of GLRX2 mRNA CTD PMID:21827849 trichloroethene increases methylation ISO RGD:1307950 6480464 Trichloroethylene results in increased methylation of GLRX2 gene CTD PMID:27618143 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of GLRX2 mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of GLRX2 mRNA CTD PMID:27188386 valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of GLRX2 mRNA CTD PMID:25979313 valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-5-benzo1, 3dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-ylbenzamide] results in increased expression of GLRX2 mRNA CTD PMID:27188386 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of GLRX2 mRNA CTD PMID:23179753 more ... vinclozolin affects expression ISO RGD:1307950 6480464 vinclozolin affects the expression of GLRX2 mRNA CTD PMID:19015723 zearalenone increases expression EXP 6480464 Zearalenone results in increased expression of GLRX2 mRNA CTD PMID:19371625